Prevention and thorough consideration of drug induced liver injury

Bai WenYuan; Liu Na

Issue 3

Mar. 2011

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2011 > 27(3): 245-247

PDF( 2529 KB)

Prevention and thorough consideration of drug induced liver injury

Bai WenYuan,
Liu Na

Published Date: 2011-03-20

Abstract

Abstract

In recent years,the incidence of drug induced liver injury(DILI) has been increasingly obvious in our country.Acute severe DILI is leading to higher death rate and affecting the public health seriously.The main factors of inducing DILI include abuse of antibiotics,impractical advertisements of medicines,using expired medicine or in inappropriate way in countrysides,etc.For these reasons,we must pay great importance to DILI and take out a feasible way to avoid the occurrence of DILI.
- liver diseases

FullText(HTML)

References(17)

References

[1]Bernal W,Auzinger G,Dhawan A,et al.Acute liver failure[J].Lancet,2010,376(9736):190-201.

[2]Russmann S,Jetter A,Kullak-Ublick GA.Pharma-cogene-tics of drug-induced liver injury[J].Hepatology,2010,52(2):748-761.

[3]尚佳,徐芸,杨玉秀,等.人工肝支持系统治疗药物性肝损伤32例[J].中华肝脏病杂志,2005,13(11):836-838.

[4]王艳,赵龙凤,王勤英.药物性肝损伤66例分析[J].中华肝脏病杂志,2010,18(9):715-716.

[5]Hunt CM.Mitochondrial and immunoallergic injury increase risk of positive drug rechallenge after drug-induced liver injury:A systematic review[J].Hepatology,2010,52(6):2216-2222.

[6]Reuben A,Koch DG,Lee WM.Drug-induced acute liver failure:Results of a U.S.multicenter,prospective study[J].Hepatology,2010,52(6):2065-2076.

[7]Ekins S,Williams AJ,Xu JJ.A predictive ligand-based bayesian model for human drug-induced liver injury[J].Drug Metab Dispos,2010,38(12):2302-2308.

[8]Vuppalanchi R,Hayashi PH,Chalasani N,et al.Dul-oxetine hepatotoxicity:a case-series from the drug-induced liver injury network[J].Aliment Pharmacol Ther,2010,32(9):1174-1183.

[9]Karatopuk DU,G?k?1men A.Effect of tenoxicam on rat liver tissue[J].Turk J Gastroenterol.2010,21(2):146-152.

[10]Kelava T,Cavar I,Culo F.Influence of small doses of various drug vehicles on acetaminophen-induced liver injury[J].Can J Physiol Pharmacol,2010,88(10):960-967.

[11]Schumaker AL,Okulicz JF.Meropenem-induced vanishing bile duct syndrome[J].Pharmacotherapy,2010,30(9):953.

[12]Nú?ez M.Clinical syndromes and consequences of antiretroviral-related hepatotoxicity[J].Hepatology,2010,52(3):1143-1155.

[13]Tai WP,Yue H,Zhai HZ.Zhixue capsule caused seven cases of drug induced hepatitis[J].Hepatogastroenterology,2010,57(99-100):571-572.

[14]Devarbhavi H,Dierkhising R,Kremers WK.Antitu-berculosis therapy drug-induced liver injury and acute liver failure[J].Hepatology,2010,52(2):798-799.

[15]Park WB,Kim W,Lee KL,et al.Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis[J].J Infect,2010,61(4):323-329.

[16]Hou FQ,Wang TL,Liu X,et al.The clinical and histological characteristics and outcomes of drug induced chronic liver injury after removing causative drugs[J].Hepatogastroenterology,2010,57(99-100):554-561.

[17]Fontana RJ.Approaches to the study of drug-induced liver injury[J].Clin Pharmacol Ther,2010,88(3):416-419.

Relative Articles

[1]	Gao YuDi, Tian Yuan, Zhang XiangYing, Zhang XiaoHui, Duan ZhongPing, Ren Feng, Chen Yu. Effect of magnesium isoglycyrrhizinate on concanavalin A-induced acute liver failure in mice[J]. Journal of Clinical Hepatology, 2020, 36(7): 1571-1576. doi: 10.3969/j.issn.1001-5256.2020.07.024
[2]	Du XiaoFei, Chen Jie, Huang ChunYang, Zhang XiaoDan, Liu Dan, Bian XinQu, Han Ying, Liu YanMin, Dan Jing. Clinical effect and safety of magnesium isoglycyrrhizinate in treatment of autoimmune-like drug-induced liver injury[J]. Journal of Clinical Hepatology, 2020, 36(6): 1330-1333. doi: 10.3969/j.issn.1001-5256.2020.06.028
[3]	Expert Committee on Clinical Application of Glycyrrhizin Preparation in the Treatment of Liver Diseases. Expert consensus on clinical application of glycyrrhizin preparation in the treatment of liver diseases[J]. Journal of Clinical Hepatology, 2016, 32(5): 844-852. doi: 10.3969/j.issn.1001-5256.2016.05.004
[4]	Li XiaoHui, Wen Yu, Jin WenHui, Hong Zhuan, Ceng MeiYan, Chen WeiZhu. Compatible stability of magnesium isoglycyrrhizinate injection and reduced glutathione for injection[J]. Journal of Clinical Hepatology, 2016, 32(1): 143-147. doi: 10.3969/j.issn.1001-5256.2016.01.028
[5]	Li XiaoPeng, Li Ming, Lei Wan, Zhang LunLi. Protective effect of magnesium isoglycyrrhizinate in rats with acute liver failure induced by D- galactosamine[J]. Journal of Clinical Hepatology, 2016, 32(3): 545-548. doi: 10.3969/j.issn.1001-5256.2016.03.032
[6]	Mao HaiYing, Kang Tao, Yao Ling, Chen Qin. Efficacy of glycyrrhizin in patients with chronic severe hepatitis B:a meta-analysis[J]. Journal of Clinical Hepatology, 2015, 31(1): 63-67. doi: 10.3969/j.issn.1001-5256.2015.01.014
[7]	Ji HuiChun, Liu QingDe, Wang HongQi, Li Juan, Zhu Yun, Sun Yang, Zhou ZhongHai, Liu JunQuan. Clinical efficacy of puerarin combined with compound ammonium glycyrrhetate S in treatment of alcoholic hepatitis[J]. Journal of Clinical Hepatology, 2014, 30(10): 1067-1070. doi: 10.3969/j.issn.1001-5256.2014.10.023
[8]	Wang XiaoPeng, Su He, Tian HongWei, Zhang SuYu, Wu ZiYan, An YaLi, Ma YunTao. Clinical efficacy of magnesium isoglycyrrhizinate in treatment of liver injury among patients with obstructive jaundice after percutaneous transhepatic cholangiodrainage[J]. Journal of Clinical Hepatology, 2014, 30(6): 563-566. doi: 10.3969/j.issn.1001-5256.2014.06.022
[9]	Luo XiaoKe, Li XiaoLing, Yang LiMing, Wang XiaoHong. Efficacy of magnesium isoglycyrrhizinate in treatment of hepatitis E with severe jaundice[J]. Journal of Clinical Hepatology, 2014, 30(6): 537-539. doi: 10.3969/j.issn.1001-5256.2014.06.014
[10]	Xu ZhongNan, Wu XiMing, Wang Pei, Zhang XiQuan, Xia ChunGuang, Wang XunQiang, Wang Yang, Zhan XiaoLe, Qu Ying, Xu MingYi, Lu LunGen. 18α glycyrrhizic acid in the treatment of acute liver injury induced by D-galactosamine in rats[J]. Journal of Clinical Hepatology, 2012, 28(1): 63-65+70.
[11]	Jing XiaoZhen, Liu Jing, Qian Hai. The therapeutic efficacy of magnesium isoglycyrrhizinate on rats with non alcoholic steatohepatitis[J]. Journal of Clinical Hepatology, 2011, 27(3): 295-297.
[12]	Suo HaiFen, Zhu YaoJu. Effect of sophocarpidine and diammonium glycyrrhizinate injection on hepatic fibrosis and the content of interferon-γ of chronicity type B Hepatitis patients[J]. Journal of Clinical Hepatology, 2010, 26(2): 196-198.
[16]	Li YunRu, Wang WenBing, Zhang LiYing, Ou YuNi, Xie Wen, Wei Lai. The analysis of efficacy of glycyrrhizin therapy for autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2007, 23(2): 117-118.
[18]	Yin HeKun, Li QiXiang, Luo Dan. The clinical study of L-ornithine-L-aspartate combined with SNMC for hepatic encephalopathy of liver cirrhosis[J]. Journal of Clinical Hepatology, 2007, 23(4): 268-269.
[20]	Li YongXin, Gao QingWei, Wang YingLan. Analysis on clinical efficacy of Thiamine and Drammonium glycyrrhizinate concerning the treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2003, 19(4): 226-227.

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (3441) PDF downloads(1061)

Prevention and thorough consideration of drug induced liver injury

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Prevention and thorough consideration of drug induced liver injury

Abstract

References

Relative Articles

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content